Vanguard Personalized Indexing Management
AUPH icon

Vanguard Personalized Indexing Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
18,052
+428
+2% +$6.84K ﹤0.01% 1694
2026
Q1 		$261K Buy
17,624
+4,753
+37% +$69.5K ﹤0.01% 1683
2025
Q4 		$205K Sell
12,871
-1,021
-7% -$14.5K ﹤0.01% 1713
2025
Q3 		$154K Buy
13,892
+2,973
+27% +$32.5K ﹤0.01% 1754
2025
Q2 		$92.5K Buy
+10,919
New +$87.5K ﹤0.01% 1752

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's AUPH Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Aurinia Pharmaceuticals (AUPH) stake by 2.4% in Q2 2026, buying an estimated $6.84K and bringing the position to 18,052 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Vanguard Personalized Indexing Management first reported a position in AUPH in Q2 2025 and has held it in 5 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Vanguard Personalized Indexing Management held 18,052 shares of Aurinia Pharmaceuticals worth $306K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 428 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $6.84K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1694 holding.
  • Vanguard Personalized Indexing Management first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.